-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Calcipotriene in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Calcipotriene in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Calcipotriene in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: Calcipotriene (calcipotriol)...
-
Product Insights
Pacemakers – Abbott Laboratories – VERITY ADX XL VDR
GlobalData, the industry analysis specialist, has released its latest report: Pacemakers - Abbott Laboratories - VERITY ADX XL VDR. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Dual Chamber Pacemaker, ABBOTT LABORATORIES, VERITY ADX XL VDR, pricing in the Brazil, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Dual Chamber Pacemaker, ABBOTT LABORATORIES, VERITY ADX XL VDR, pricing in the Brazil, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – calcipotriene
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry calcipotriene Drug Details Calcipotriene (calcipotriol) is under development for the treatment of psoriasis vulgaris...
-
Product Insights
Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of...